Not exact matches
The U.S. Food and Drug Administration originally approved the drug in 1999, but subsequent case reports of abnormal behavior in
adolescents who used the medication led the agency in 2006 to require that all packaging of the drug include a warning
label about potential neuropsychiatric side effects, such
as hallucinations, delirium, self - harm and even suicide.
Bratteby LE, Sandhagen B, Fan H, Enghardt H, Samuelson G. Total energy expenditure and physical activity
as assessed by the doubly
labeled water method in Swedish
adolescents in whom energy intake was underestimated by 7 - d diet records.
A disciplinary strategy
labeled as «power - assertive,» characterized by corporal and psychological aggression, in combination with high levels of supervision and punishment was positively related to
adolescent - to - parent violence (Ibabe and Bentler 2016).